期刊文献+

吉非替尼的合成工艺改进 被引量:3

Study of the Synthesis Te chnology of Gefitinib
下载PDF
导出
摘要 以3,4-二甲氧基苯甲酸为原料,经硝化、脱甲基、还原、环合、乙酰化、氯化、缩合、水解等反应,最后经过一步与N-(3-氯丙基)吗啉缩合得到抗肿瘤药吉非替尼。 Gefitinib was synthesized from 3,4-dimethoxy benzoic acid by nitrification, demethylation, reduction, cyclization, acetylation, chlorination,condensation, hydrolysis, and the final condensation with N-(3- chloropropyl) morpholine.
出处 《药学与临床研究》 2015年第2期147-149,共3页 Pharmaceutical and Clinical Research
关键词 吉非替尼 EGFR酪氨酸激酶抑制剂 合成 Gefitinib EGFR tyrosine kinase inhibitors Synthesis
  • 相关文献

参考文献4

二级参考文献41

  • 1张艳华,宁华,姜洋.表皮生长因子受体酪氨酸激酶抑制剂吉非替尼[J].中国新药杂志,2004,13(10):947-950. 被引量:13
  • 2张竹霞,吕荣文,张珂珂,高昆玉.水合肼还原芳硝基物的研究[J].精细化工,2001,18(4):239-242. 被引量:54
  • 3[1]Natale R,Zaretsky SL.ZD1839 (IressaTM):what's in it for the patient[J].The Oncologist,2002,7(Suppl 4):S25-S30. 被引量:1
  • 4[2]Herbst RS,Kies MS.ZD1839 (IressaTM) in non-small-cell lung cancer[J].The Oncologist,2002,7(Suppl 4):S9-S15. 被引量:1
  • 5[3]Barker AJ,Gibson KH,Grundy W,et al.Studies leading to the identification of ZD1839(IRESSA):an orally active,selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer[J].Bioorg Med Chem,2001,11(14):1911-1914. 被引量:1
  • 6[4]Iwasawa A,Kumamoto Y,Fujinaga K.Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization[J].J Urol,1993,149(1):59-63. 被引量:1
  • 7[5]Varma VA,Sancher LMM,Unger ER,et al.Association of human papillomavirus with penile carcinoma:a study using polymerase chain reaction and in situ hybridization[J].Hum Pathol,1991,22(9):908-913. 被引量:1
  • 8[6]Gorgoulis V,Aninos D,Mikou P,et al.Quantitative assay of epidermal growth rceptor in squamous cell lung carcinomas[J].Anti Cancer Res,1992,12(4):1183. 被引量:1
  • 9[7]Swaisland H,Laight A,Stafford L,et al.Pharmacokinetics and tolerability of the orally active selective epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in healthy volunteers[J].Clin Pharmacokinet,2001,40(4):297-306. 被引量:1
  • 10[8]Alderley P.ZD1839 ('Iressa'),an oral EGFR-TKI:pharmacokinetic results of a phase Ⅰstudy in patients with advanced cancer[A].AACR[C].San Francisco,CA,April 1-5,2000. 被引量:1

共引文献25

同被引文献22

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部